company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20694000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20694000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3540000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3540000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17154000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3386000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5603000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2407000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11396000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5758000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-85000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-81000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5677000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,197000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5480000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5480000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5480000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q2,2010-04-01,2010-06-30,2011-08-09 16:42:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22840000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22840000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3146000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3146000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19694000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3820000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5445000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2618000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11883000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7811000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,64000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,76000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7887000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,259000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7628000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7628000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7628000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2010.0,Q3,2010-07-01,2010-09-30,2011-11-09 16:05:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21662000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21662000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3103000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3103000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18559000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5958000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5228000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3109000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,0.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14295000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4264000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,15000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4242000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,393000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3849000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3849000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3849000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48100000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48100000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48100000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q1,2011-01-01,2011-03-31,2013-04-01 17:05:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31926000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31926000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4205000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4205000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27721000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8259000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12771000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3091000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,714000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25643000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2078000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,53000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,13000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-44000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2034000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,143000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1891000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1891000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1891000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63000000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63000000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.03
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47300000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q2,2011-04-01,2011-06-30,2013-04-01 17:08:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39302000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39302000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6262000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6262000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33040000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5202000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15058000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3035000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,858000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-2231000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21922000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11118000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-39000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11079000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,247000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10832000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58331000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58331000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58331000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q3,2011-07-01,2011-09-30,2013-04-01 17:25:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39675000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39675000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5839000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5839000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33836000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4613000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15796000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3111000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,893000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1423000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-3495000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22341000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11495000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-27000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11437000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-113000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,55110000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.21
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55110000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,55110000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.21
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41068000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41068000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5532000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5532000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35536000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3961000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3393000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,884000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-916000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10574000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,30000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,10548000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,883000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9665000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9665000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9665000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57701000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57701000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57701000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q1,2012-01-01,2012-03-31,2013-08-09 06:07:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41369000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41369000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5664000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5664000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35705000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4455000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17504000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1493000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,882000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-1171000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23163000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12542000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,55000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-14000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-54000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12488000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1260000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11228000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11228000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11228000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,57239000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,57239000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,57239000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q2,2012-04-01,2012-06-30,2013-08-09 06:11:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40693000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40693000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5474000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5474000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,35219000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5673000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,17063000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,864000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,879000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-12773000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,42728000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54434000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19215000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,57000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,28000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-36000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19251000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-6090000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13161000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13161000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13161000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56617000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56617000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56617000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q3,2012-07-01,2012-09-30,2013-11-12 17:18:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33139000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33139000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5326000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5326000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27813000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7255000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,18120000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,-605000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,14860000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1096000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-15422000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25304000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2509000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-22000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2487000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,599000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1888000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56637000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.03
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58483000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56600000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.03
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29806000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29806000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4618000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4618000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25188000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8600000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,11199000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,365000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20164000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5024000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4990000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,787000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4203000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4203000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4203000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54084000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54084000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54084000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:06:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29292000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29292000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3205000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3205000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26087000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7954000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14269000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5406000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27629000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1542000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,45000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,12000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,80000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,47000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1495000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,488000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1983000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1983000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1983000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,54124000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.04
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54124000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.04
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49600000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q2,2013-04-01,2013-06-30,2014-08-11 17:02:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.04
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,35226000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,35226000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3808000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,31418000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8238000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,16498000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,550000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25286000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6132000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2711000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2729000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8861000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,153000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8708000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8708000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8708000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53591000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,55070000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54400000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q3,2013-07-01,2013-09-30,2014-11-10 16:58:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32734000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32734000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6037000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6037000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26697000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7704000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13274000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1723000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,2000000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1181000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25882000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,815000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,8000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,20000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,35000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,850000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,814000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,36000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,36000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,36000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,53587000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54936000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,54800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26565000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26565000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4561000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4561000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,22004000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6033000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,9834000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1476000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17343000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4661000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,29000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,19000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-119000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-129000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4532000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,398000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4134000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4134000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4134000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52026000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53234000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q1,2014-01-01,2014-03-31,2015-05-11 16:43:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,32513000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,32513000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5011000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5011000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,27502000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5816000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,11242000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,804000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17862000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,19000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,23000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,30000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9674000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9640000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51620000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.19
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52812000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.18
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50700000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q2,2014-04-01,2014-06-30,2015-08-10 16:41:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.19
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,34287000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,34287000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6005000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6005000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28282000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5611000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13911000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,653000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20175000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8107000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,31000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,108000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,139000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8246000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,331000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7915000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7915000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7915000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51032000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52393000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49500000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:32:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,41425000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,41425000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7425000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7425000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34000000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5286000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13490000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11648000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30424000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3576000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,88000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,261000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,349000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3925000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,406000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3519000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3519000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3519000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51277000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52684000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,51400000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,33568000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,33568000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4597000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4597000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28971000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7044000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,11356000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1088000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19488000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9483000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,112000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-63000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,49000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9532000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,570000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8962000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49964000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.18
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52278000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:29:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.18
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,37946000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,37946000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5681000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5681000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,32265000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6424000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13317000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6581000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37122000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-4857000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,250000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,39000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,289000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-4568000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-546000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4022000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4022000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-4022000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49929000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49929000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50300000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 16:32:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42880000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42880000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6853000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6853000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36027000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7294000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15073000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1039000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,26000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23432000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12595000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,252000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-281000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12566000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,587000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11979000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11979000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11979000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49869000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52126000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49900000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q3,2015-07-01,2015-09-30,2016-11-09 16:32:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42863000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42863000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5217000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5217000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,37646000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7135000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14215000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3606000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24956000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12690000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,255000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-205000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,50000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12740000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,196000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49797000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52173000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49900000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,36499000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,36499000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5813000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5813000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30686000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7443000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12352000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1467000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21262000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9424000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,259000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,128000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,387000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,9811000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1947000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7864000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7864000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7864000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49589000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,51955000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.15
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49200000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:30:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,38991000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,38991000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5712000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5712000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,33279000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8129000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14432000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4765000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27326000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5953000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,263000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-249000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5967000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-371000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6338000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49897000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52819000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:16:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,40544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,40544000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5585000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5585000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,34959000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7900000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,13320000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3288000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24508000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,10451000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,270000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,451000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,721000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11172000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1056000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10116000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10116000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10116000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50379000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52595000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.19
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50600000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q3,2016-07-01,2016-09-30,2016-11-09 16:32:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44062000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44062000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5788000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5788000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38274000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10709000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,14600000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5558000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,30867000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7407000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,270000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-494000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-224000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7183000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,772000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6411000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6411000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6411000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50235000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52566000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.12
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50400000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,42892000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,42892000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6165000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6165000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,36727000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7230000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,12765000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2495000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22490000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14237000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,296000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1075000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1371000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15608000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1012000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14596000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14596000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14596000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51437000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53009000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52100000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:30:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44520000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44520000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5654000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5654000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38866000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8286000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,15435000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2828000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26549000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,12317000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,297000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,167000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,464000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12781000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,589000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12192000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51820000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,53252000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50800000.0
SciClone Pharmaceuticals Inc,SCLN,,0000880771,2017.0,Q2,2017-04-01,2017-06-30,2017-08-09 16:16:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
